Meta Pixel

News and Announcements

How to Build your Capital Raising Brand

  • Published December 07, 2022 3:10AM UTC
  • Publisher Osama Hassan
  • Categories Capital Raising Tips

When raising capital, one of the best things you can do is build your Capital Raising Brand. This is what builds your case to an investor. 

Typically, investors will have 30-50 other founders competing for their attention, and so by building your brand, you effectively communicate your offering to investors in the shortest amount of time possible.

Here are 7 Capital Raising Brand Elements —

1) Board and Management: communicates capacity to execute well.

2) Team: the skillset of the talent in your company demonstrates underlying potential.

3) Existing Investors: if VCs, high-profile HNWs, and other investment groups have invested in your company, then by highlighting that to other investors, you’re communicating that reputable investors have already done their due-diligence on your company.

4) Awards: communicates that your industry recognises your value-add.

5) Grants: R&D grants, and the like, are testament to a company’s capacity to innovate.

6) Sector: captures the attention of investors interested in a particular sector.

7) Metrics: demonstrates credibility and growth potential.

All of these brand elements help you go from unknown to known, and most importantly, communicate and establish trust. Investors are well aware of the high risk early stage investments carry; what really communicates value to them is how efficiently you can capture their interest and establish trust.

What do you think communicates a company’s capital raising brand?

✌️

Click here to view the original Linkedin post.

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now